Respirační symptomy, bronchitida a astma dětí střední a východní Evropy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F71009396%3A_____%2F02%3A%230000033" target="_blank" >RIV/71009396:_____/02:#0000033 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe

Popis výsledku v původním jazyce

The cross-sectional multicentre CESAR study aimed to measure the respiratory health of schoolchildren using a standardised questionnaire in six CEE countries in 1996, allowing comparisons within this region and with other European countries. Parents of 21,743 schoolchildren of age 7-11 yrs completed a questionnaire on cough and wheeze symptoms, as well as on diagnoses by doctors. Life-time prevalence of bronchitis was 55.9%, asthma 3.9%, and asthmatic, spastic or obstructive bronchitis 12.3%. In CEE countries the prevalence of bronchitis is higher and prevalence of asthma appears lower than in Western Europe. However, if asthma is defined as a diagnosis of either asthma or asthmatic, spastic or obstructive bronchitis, then its prevalence is comparableto Western Europe, or higher. Between-country comparisons in doctors' diagnoses appear dependent on the choice of definition of asthma. Some of the East-West difference in asthma prevalence may be attributable to differences in diagnostic

Název v anglickém jazyce

Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe

Popis výsledku anglicky

The cross-sectional multicentre CESAR study aimed to measure the respiratory health of schoolchildren using a standardised questionnaire in six CEE countries in 1996, allowing comparisons within this region and with other European countries. Parents of 21,743 schoolchildren of age 7-11 yrs completed a questionnaire on cough and wheeze symptoms, as well as on diagnoses by doctors. Life-time prevalence of bronchitis was 55.9%, asthma 3.9%, and asthmatic, spastic or obstructive bronchitis 12.3%. In CEE countries the prevalence of bronchitis is higher and prevalence of asthma appears lower than in Western Europe. However, if asthma is defined as a diagnosis of either asthma or asthmatic, spastic or obstructive bronchitis, then its prevalence is comparableto Western Europe, or higher. Between-country comparisons in doctors' diagnoses appear dependent on the choice of definition of asthma. Some of the East-West difference in asthma prevalence may be attributable to differences in diagnostic

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FQ - Veřejné zdravotnictví, sociální lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

R - Projekt Ramcoveho programu EK

Rok uplatnění

2002

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Respiratory Journal

ISSN

0903-1936

e-ISSN

—

Svazek periodika

20

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

9

Strana od-do

890-898

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—